These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31491944)

  • 1. Closing the Gap in Surveillance and Audit of Invasive Mold Diseases for Antifungal Stewardship Using Machine Learning.
    Baggio D; Peel T; Peleg AY; Avery S; Prayaga M; Foo M; Haffari G; Liu M; Bergmeir C; Ananda-Rajah M
    J Clin Med; 2019 Sep; 8(9):. PubMed ID: 31491944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toward Electronic Surveillance of Invasive Mold Diseases in Hematology-Oncology Patients: An Expert System Combining Natural Language Processing of Chest Computed Tomography Reports, Microbiology, and Antifungal Drug Data.
    Ananda-Rajah MR; Bergmeir C; Petitjean F; Slavin MA; Thursky KA; Webb GI
    JCO Clin Cancer Inform; 2017 Nov; 1():1-10. PubMed ID: 30657390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EPICO 3.0. Empirical antifungal therapy in critically-ill hematology patients.
    Llinares P; Ruiz I; Zaragoza R; Ferrer R; Rodríguez AH; Maseda E; Grau S;
    Rev Iberoam Micol; 2016; 33(4):206-215. PubMed ID: 27751781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ushering in Antifungal Stewardship: Perspectives of the Hematology Multidisciplinary Team Navigating Competing Demands, Constraints, and Uncertainty.
    Ananda-Rajah MR; Fitchett S; Ayton D; Peleg AY; Fleming S; Watson E; Cairns K; Peel T
    Open Forum Infect Dis; 2020 Jun; 7(6):ofaa168. PubMed ID: 32577425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Facilitating surveillance of pulmonary invasive mold diseases in patients with haematological malignancies by screening computed tomography reports using natural language processing.
    Ananda-Rajah MR; Martinez D; Slavin MA; Cavedon L; Dooley M; Cheng A; Thursky KA
    PLoS One; 2014; 9(9):e107797. PubMed ID: 25250675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Auditing fungal disease in leukemia patients in a tertiary care center: opportunities and challenges for an antifungal stewardship program.
    Paige E; Haywood P; Xie M; Worth L; Thursky K; Urbancic K; Bajel A; Slavin M
    Leuk Lymphoma; 2019 Oct; 60(10):2373-2383. PubMed ID: 31096813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic antifungal prophylaxis after hematopoietic stem cell transplantation: a meta-analysis.
    Ziakas PD; Kourbeti IS; Mylonakis E
    Clin Ther; 2014 Feb; 36(2):292-306.e1. PubMed ID: 24439393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum galactomannan-based early detection of invasive aspergillosis in hematology patients receiving effective antimold prophylaxis.
    Duarte RF; Sánchez-Ortega I; Cuesta I; Arnan M; Patiño B; Fernández de Sevilla A; Gudiol C; Ayats J; Cuenca-Estrella M
    Clin Infect Dis; 2014 Dec; 59(12):1696-702. PubMed ID: 25165088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of invasive mold diseases in patients with hematological malignancies using Aspergillus, Mucorales, and panfungal PCR in BAL.
    Wehrle-Wieland E; Affolter K; Goldenberger D; Tschudin Sutter S; Halter J; Passweg J; Tamm M; Khanna N; Stolz D
    Transpl Infect Dis; 2018 Oct; 20(5):e12953. PubMed ID: 29896857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Characteristics, Health Care Utilization, and Outcomes Among Patients in a Pilot Surveillance System for Invasive Mold Disease-Georgia, United States, 2017-2019.
    Gold JAW; Revis A; Thomas S; Perry L; Blakney RA; Chambers T; Bentz ML; Berkow EL; Lockhart SR; Lysen C; Nunnally NS; Jordan A; Kelly HC; Montero AJ; Farley MM; Oliver NT; Pouch SM; Webster AS; Jackson BR; Beer KD
    Open Forum Infect Dis; 2022 Jul; 9(7):ofac215. PubMed ID: 35794945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study.
    Maertens J; Theunissen K; Verhoef G; Verschakelen J; Lagrou K; Verbeken E; Wilmer A; Verhaegen J; Boogaerts M; Van Eldere J
    Clin Infect Dis; 2005 Nov; 41(9):1242-50. PubMed ID: 16206097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Diagnostics-Driven Antifungal Stewardship in the Management of Invasive Fungal Infections: A Systematic Literature Review.
    Chakrabarti A; Mohamed N; Capparella MR; Townsend A; Sung AH; Yura R; Muñoz P
    Open Forum Infect Dis; 2022 Jul; 9(7):ofac234. PubMed ID: 35873300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifungal Stewardship in Invasive Fungal Infections, a Systematic Review.
    Procacci C; Marras L; Maurmo L; Vivanet G; Scalone L; Bertolino G
    Adv Exp Med Biol; 2024 Feb; ():. PubMed ID: 38337088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of CT assessment in hematology patients with invasive aspergillosis: a post-hoc analysis of phase 3 data.
    Jin J; Wu D; Liu Y; Pan S; Yan JL; Aram JA; Lou YJ; Meng H; Chen X; Zhang X; Schwartz IS; Patterson TF
    BMC Infect Dis; 2019 May; 19(1):471. PubMed ID: 31138134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Azole-based chemoprophylaxis of invasive fungal infections in paediatric patients with acute leukaemia: an internal audit.
    Yunus S; Pieper S; Kolve H; Goletz G; Jürgens H; Groll AH
    J Antimicrob Chemother; 2014 Mar; 69(3):815-20. PubMed ID: 24198097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifungal stewardship in a tertiary-care institution: a bedside intervention.
    Valerio M; Muñoz P; Rodríguez CG; Caliz B; Padilla B; Fernández-Cruz A; Sánchez-Somolinos M; Gijón P; Peral J; Gayoso J; Frias I; Salcedo M; Sanjurjo M; Bouza E;
    Clin Microbiol Infect; 2015 May; 21(5):492.e1-9. PubMed ID: 25748494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The case for antifungal stewardship.
    Ananda-Rajah MR; Slavin MA; Thursky KT
    Curr Opin Infect Dis; 2012 Feb; 25(1):107-15. PubMed ID: 22123667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breakthrough invasive aspergillosis and diagnostic accuracy of serum galactomannan enzyme immune assay during acute myeloid leukemia induction chemotherapy with posaconazole prophylaxis.
    Calmettes C; Gabriel F; Blanchard E; Servant V; Bouchet S; Kabore N; Forcade E; Leroyer C; Bidet A; Latrabe V; Leguay T; Vigouroux S; Tabrizi R; Breilh D; Accoceberry I; de Lara MT; Pigneux A; Milpied N; Dumas PY
    Oncotarget; 2018 Jun; 9(42):26724-26736. PubMed ID: 29928481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment outcomes in patients with proven/probable vs possible invasive mould disease in a phase III trial comparing isavuconazole vs voriconazole.
    Maertens J; Selleslag D; Heinz WJ; Saulay M; Rahav G; Giladi M; Aoun M; Kovanda L; Kaufhold A; Engelhardt M; Cornely OA; Herbrecht R; Ullmann AJ
    Mycoses; 2018 Nov; 61(11):868-876. PubMed ID: 30035825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complications of hematopoietic stem transplantation: Fungal infections.
    Omrani AS; Almaghrabi RS
    Hematol Oncol Stem Cell Ther; 2017 Dec; 10(4):239-244. PubMed ID: 28636889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.